跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,732 条关于
“Hi-Bio”
全部
5,732
临床试验
2,532
药物
1,060
机构
274
资讯
1,866
2年前
Biogen Expands into Immunology with Acquisition of HI-Bio
去年
Biogen Initiates Phase 3 TRANSCEND Trial of Felzartamab for Late Antibody-Mediated Kidney Transplant Rejection
去年
Biogen's Felzartamab Receives FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
去年
Biogen's Felzartamab Shows Promising Results in IgA Nephropathy Phase 2 Trial
去年
Biogen's Felzartamab Shows Promise in Phase 2 IgAN Trial
去年
Biogen's Felzartamab Shows Sustained Efficacy in IgA Nephropathy Phase 2 Trial
5个月前
Jeito Capital Closes Record $1.2 Billion Fund to Accelerate European Biopharma Innovation
去年
Braveheart Bio Raises $185M Series A to Advance Hypertrophic Cardiomyopathy Drug Licensed from Hengrui
去年
Biogen's Leqembi Shows Accelerating Growth with 58% Global Sales Increase Despite Slow Market Adoption
去年
Maxion Therapeutics Strengthens Leadership with Appointment of Dr. Stefan Härtle as Chief Development Officer
第 1 页,共 187 页
上一页
下一页